Placental stem cell markers in pre-eclampsia

Int J Gynaecol Obstet. 2008 Mar;100(3):228-33. doi: 10.1016/j.ijgo.2007.09.023. Epub 2007 Nov 28.

Abstract

Objective: To investigate the placental CD34, CD44, and leukemia inhibitory factor (LIF) levels in normotensive and pre-eclamptic women.

Method: The study population consisted of 21 women with pre-eclampsia. Twenty normotensive pregnant women served as controls and were matched to pre-eclamptic patients by gestational age at delivery. Decidual samples obtained from the central part of the placenta were stored at -70 degrees C until analysis. CD44 and LIF were quantified in homogenates by enzyme-linked immunosorbent assay (ELISA), while CD34 was quantified by flow cytometry.

Results: The pre-eclamptic and normotensive groups were well matched. There were no significant differences in age, parity, weight, and gestational age at birth between the groups (P>0.05). The mean placental levels of CD34 (6.55+/-2.48 vs 3.16+/-1.23), CD44 (385.24+/-178.85 vs 157.75+/-31.73, and LIF (140+/-51.11 vs 96.25+/-31.62) were significantly higher in pre-eclamptic compared with normotensive women, respectively (P<0.05).

Conclusion: Higher levels of CD34, CD44, and LIF were found in the placentas of pre-eclamptic compared with normotensive women.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antigens, CD34 / metabolism*
  • Biomarkers / metabolism
  • Case-Control Studies
  • Female
  • Humans
  • Hyaluronan Receptors / metabolism*
  • Infant, Newborn
  • Leukemia Inhibitory Factor / metabolism*
  • Placenta / cytology
  • Placenta / metabolism*
  • Pre-Eclampsia / metabolism*
  • Pregnancy
  • Stem Cells / metabolism*

Substances

  • Antigens, CD34
  • Biomarkers
  • Hyaluronan Receptors
  • Leukemia Inhibitory Factor